FDA Authorizes First Continuous Glucose-Ketone Monitor

The U.S. Food and Drug Administration on August 25 authorized Abbott Diabetes Care’s Libre Duo 10 Day system for people aged 2 and older with diabetes. The wearable continuously measures ketones and glucose together and can alert users when ketones reach a concerning threshold. The authorization introduces continuous ketone monitoring alongside established glucose tracking in […]